Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 110 clinical trials
Effects of Long-Term Administration of Human Albumin in Subjects With Decompensated Cirrhosis and Ascites (PRECIOSA)

versus SMT alone in subjects with decompensated cirrhosis and ascites. The study population will consist of subjects being discharged after hospitalization for acute decompensation of liver cirrhosis

  • 33 views
  • 27 Feb, 2022
  • 29 locations
Study Looking at Biomarkers in Ovarian Cancer

This is a sample study that will collect biological samples (blood, tumor tissue, ascites, and/or other fluids) from gynecological cancer patients for biomarker research. In addition, the

cancer
ovarian cancer
  • 92 views
  • 26 Feb, 2022
  • 6 locations
A Phase II Study of OsrHSA in Patients With Decompensated Cirrhotic Ascites

The study is designed to study the efficacy of IV OsrHSA or positive control HSA (10 g and 20 g IV everyday) for 14 days. After a screening period of up to 14 days, the eligible subjects will be randomized in a 4:1 ratio to OsrHSA and positive control HSA, …

  • 0 views
  • 24 Nov, 2021
  • 1 location
Recombinant Human Serum Albumin in Healthy Subjects

This trial adopts a single-center, randomized, double-blind, dose-escalation, placebo-controlled design to evaluate the safety, tolerability, pharmacokinetics, and efficacy of a single administration of recombinant human serum albumin in healthy subjects Kinetics and anti-drug antibody characteristics. Qualified healthy subjects (both male and female) were screened and enrolled to the four dose …

Accepts healthy volunteers
  • 0 views
  • 24 Mar, 2022
  • 1 location
Recombinant Human Serum Albumin in Patients With Liver Cirrhosis and Ascites Subjects

preliminary effectiveness of recombinant human serum albumin in patients with liver cirrhosis and ascites subjects (both male and female) were screened and enrolled to the three dose levels of 10g, 20

  • 0 views
  • 12 Mar, 2022
  • 1 location
Intraperitoneal Injection of Oncolytic Viruses H101 for Patients With Refractory Malignant Ascites

Assessment of effectiveness and local immune activation of Oncolytic Viruses H101 in patients with refractory malignant ascites.

  • 11 views
  • 24 Apr, 2021
  • 1 location
Oncolytic Virotherapy Plus PD-1 Inhibitor for Patients With Refractory Malignant Ascites

The objective of this study is to evaluate the safety/tolerability efficacy of oncolytic virotherapy combined with Tislelizumab for patients with refractory malignant ascites.

  • 0 views
  • 27 Apr, 2022
  • 1 location
Intratumoral Bromelain + Acetylcysteine in Relapsed and Unresectable Pseudomyxoma Peritonei

order to decrease tumoral volume. Secondary endpoints are the decrease of ascites, compressive symptoms and pain through the dilution of mucins, which would better intestinal blockage.

  • 0 views
  • 19 Apr, 2022
  • 1 location
Evaluation of PLD Combined With Carboplatin Versus Paclitaxel Plus Carboplatin in the First-line Treatment of Epithelial Ovarian Cancer

This is a randomized, multicenter, open, controlled Post-Marketing Study. 396 patients who were histopathology or exfoliated cell pathology of pleural and ascites confirmed with epithelial

  • 64 views
  • 24 Jan, 2021
  • 1 location
Dual Energy CT as a Noninvasive Method to Screen for Gastroesophageal Varices

varices, and allows for assessment of para-esophageal varices, varices in other body locations, ascites, other signs of portal hypertension, patency of liver vasculature, and detection, diagnosis and

  • 0 views
  • 04 Nov, 2021
  • 1 location